Home / Bioanalytical and biomarker services / Bioanalytical method validation / Existing bioassays
Existing bioassays
Established methods tailored to measure specific rare disease biomarkers and support critical efficacy outcomes.
Standardized assays for primary outcomes
We rely on proven bioassays to quantify critical biomarkers and safety signals for your rare disease program. Our senior scientists help you establish the exact context of use early, so your clinical data remains strictly fit for purpose.
Reliable data generation for critical markers
We ensure every assay generates defensible data that aligns with rigorous FDA and EMA expectations for primary and secondary outcomes.
Protein analysis
We perform comprehensive protein quantification and localization to support therapeutic development.
DNA/RNA quantitation
We employ sensitive molecular assays to accurately quantify gene expression and genetic targets from minimal sample input.
Immunogenicity assessment
We carry out robust immunogenicity testing to characterize immune responses and support the safety evaluation of biologic therapies.
View our bioassay capabilities
Engage our senior scientists to discuss how our existing methods can support your biomarker strategy.
Adapting to your study design
AGADA Biosciences acts as a collaborative partner built to integrate directly into your existing vendor ecosystem.
Direct access:
Senior scientists provide direct input on validation plans before laboratory work begins, ensuring regulatory alignment.
Clear accountability:
We manage specialized workflows without requiring full control of your trial.
Harmonized workflows:
We align efficacy studies and clinical SOPs to streamline transitions and reduce technology transfer time.
Submission readiness:
You receive defensible data packages designed to withstand rigorous agency scrutiny.
Efficient execution from sample receipt to final report
Our lean model ensures fast escalation paths and predictable schedules for all clinical sample testing.
Flexible protocol integration
We rapidly apply your existing protocols or develop tailored instructions suited to your specific program needs. Our team coordinates smoothly with central laboratories to receive and process serum or tissue samples securely.
Broad capabilities across specialized endpoints
AGADA Biosciences applies focused expertise across established models of muscular dystrophy. We understand the unique challenges of measuring subtle biomarker signals and deliver data that accelerates progress.
Context of use focus:
Assays are aligned strictly with the anticipated clinical readouts of your program to ensure fit-for-purpose data.
Data accessibility:
We share secure data portal access to ensure your team receives results without unnecessary administrative delays.
Continuous oversight:
Senior researchers actively monitor assay performance to protect data integrity and interpretability.
Protein expression:
We apply proven capillary Western blot protocols to reliably quantify target proteins across tissue samples.
Start a conversation
Reach out to our team to discuss your program needs and biomarker testing requirements.
Where history meets innovation
In the heart of downtown Halifax, AGADA has transformed a historic building into a modern facility dedicated to advancing rare disease therapeutics. Take a closer look at our laboratories, scientific capabilities and dedicated team and discover how our unique location and collaborative environment support the work we do for clients and patients worldwide.
Quality and compliance
We operate in strict compliance with GCP, GLP and GDPR regulations to ensure your data remains interpretable and defensible. Every team member must hold a CITI certification before supporting any sponsor trial.
Meet our scientific leadership
Our founders and senior scientists are globally recognized leaders in rare and neuromuscular disease research, bringing decades of specialized expertise to your program.
News and resources
AGADA Biosciences rapidly applies established bioassays to quantify critical biomarkers and support your efficacy studies.
